Estás en: / Inicio / Investigaciones / A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

ACTUALIDAD

A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

30/09/2020

INVESTIGADOR:

Dr. José F. Alfonso Sánchez
ACTIVO

A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

INVESTIGADOR:

PATOLOGÍA: Distrofia de Fuchs

TRATAMIENTO: Ripasudil

CÓDIGO DE ESTUDIO: K-321-201

PROMOTOR: Kowa Research Institute

PÍDENOS CITA AHORA

Déjanos tus datos

LLÁMANOS POR TELÉFONO

ESTAMOS EN

OVIEDO

MADRID